🇺🇸 FDA

Intelligence Platform

Patents

Browse 3,063 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 8557788

Prevention of tissue ischemia and related compositions

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Oct 15 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 10 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8557250

Methods for preparing complex multivalent immunogenic conjugates

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Oct 15 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 10 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8556882

Inducible interleukin-12

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Oct 15 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 10 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8551936

Defensin-antigen fusion proteins

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Oct 08 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 03 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8551536

Nitrite and nitrite-metheme therapy to detoxify stroma-free hemoglobin based blood substit

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Oct 08 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 03 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8546524

Smoothened polypeptides and methods of use

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Oct 01 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 26 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8546091

AKT phosphorylation at Ser473 as an indicator for taxane-based chemotherapy

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Oct 01 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 26 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8545888

Tendon stem cells

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Oct 01 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 26 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8541221

Primate T-lymphotropic viruses

The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention · Granted Tue Sep 24 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 19 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8536148

Disabling autophagy as a treatment for lysosomal storage diseases

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Sep 17 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 12 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8535639

Trifunctional imaging agent for monoclonal antibody tumor-targeted imaging

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Sep 17 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 12 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8530626

Methods to produce keratin elastomer

The United States of America, as represented by the Secretary of Agriculture · Granted Tue Sep 10 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 05 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8530167

Diagnostic and therapeutic uses of GNPTAB, GNPTG, and NAGPA in stuttering

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Sep 10 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 05 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8524239

Photosensitizing antibody-fluorophore conjugates

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Sep 03 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 29 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8524247

Rabies virus-based recombinant immunocontraceptive compositions and methods of use

The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention · Granted Tue Sep 03 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 29 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8524248

Methods to diagnose and immunize against the virus causing human Merkel cell carcinoma

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Sep 03 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 29 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8524482

Method and system for sampling and separating submicron-sized particles based on density a

The United States of America as represented by the Secretary of the Army · Granted Tue Sep 03 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 29 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8518968

Hydrazone and diacyl hydrazine compounds and methods of use

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Aug 27 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 22 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8518647

Method of diagnosing poor survival prognosis colon cancer using miR-16b

The United States of America as Represented by The Secretary of the Department of Health and Human Services National Institutes of Health Office of Technology Transfer · Granted Tue Aug 27 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 22 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8518957

Methanocarba adenosine derivatives, pharmaceutical compositions, and method of reducing in

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Aug 27 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 22 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8513214

C4′-substituted-2-deoxyadenosine analogs and methods of treating HIV

The United States of America as represented by the Secretary of the Dept. of Health & Human Services · Granted Tue Aug 20 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 15 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8512991

Beta 1,4-galactosyltransferases with altered donor and acceptor specificities, composition

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Aug 20 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 15 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8513005

DNA immunogenic composition comprising a full-length modified poxvirus L1R gene fused to a

The United States of America as represented by the Secretary of the Army · Granted Tue Aug 20 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 15 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8507433

Cardioprotective effects of GHRH agonists

THE UNITED STATES OF AMERICA REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS · Granted Tue Aug 13 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 08 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted